Released on = August 15, 2007, 12:32 pm

Press Release Author = Tom McCarthy

Industry = Biotech

Press Release Summary = new non-contact technology replaces the pen spotting
methodology typically used for microarray printing. Our engineers and technologists
have considerable experience in high density array manufacturing having co-developed
the system used by Codelink for the entire Human Genome Array.

Press Release Body = This new non-contact technology replaces the pen spotting
methodology typically used for microarray printing. Our engineers and technologists
have considerable experience in high density array manufacturing having co-developed
the system used by Codelink for the entire Human Genome Array.

First Phase Technologies a Tempe, Arizona based electronic contract manufacturer
announces the unveiling of a new non-contact microarrayer. This new state of the art
microarrayer printing system from Engineering Arts allows us to produce \"On-The-Fly\"
high speed array manufacturing in microscope slide, 16 assay, microplate or
lab-on-chip formats" according to CEO Tom McCarthy. Mr McCarthy also goes on to
explain "the reason why we think this new non-contact microarrayer is a benefit to
researchers is the 100% inline droplet inspection with a flexible droplet / spot
size (60pl to 10nl) which can provide pre-synthesized chemical deposition for a wide
range of chemicals such as oligos, cDNA, Proteins, Peptides, etc. This new
capability substantially lowers assay costs by enabling more assays per slide and
less target per assay than 1 assay per microscope slide formats."

This new non-contact technology replaces the pen spotting methodology typically used
for microarray printing. Our engineers and technologists have considerable
experience in high density array manufacturing having co-developed the system used
by Codelink for the entire Human Genome Array. First Phase Technologies is looking
to partner with genomic research companies as well as antibody and tissue suppliers
to produce and provide custom microarrays to the end customer. Utilizing this new
printing technology platform, this value added service will cut out much of the
unnecessary manufacturing steps allowing the researcher to focus on his or her
specific assay application or diagnostic function.

For more information on microarrays, non-contact printing services or collaborative
opportunities please visit their company web site at or call them at (480) 283-3205


Web Site = http://www.firstphasetech.com

Contact Details = Tom McCarthy
First Phase Technologies
480-967-1100